Aim: To explore the modulatory effect of desensitized α7-containing nicotinic receptors (α7-nAChRs) on excitatory and inhibitory amino acid receptors in cultured hippocampal neurons and to identify the mechanism underlying this effect. Methods: Whole-cell patch-clamp recordings were performed on cultured rat hippocampal neurons to measure α7-nAChR currents and to determine the role of desensitized α7-nAChRs on brain amino acid receptor activity. Results: Pulse and perfusion applications of the α7-nAChR agonist choline were applied to induce different types of α7-nAChR desensitization in cultured hippocampal neurons. After a brief choline pulse, α7-nAChR was desensitized as a result of receptor activation, which reduced the response of the A type γ-aminobutyric acid (GABA A ) receptor to its agonist, muscimol, and enhanced the response of the NMDA receptor to its agonist NMDA. By contrast, the responses of glycine or AMPA receptors to their agonists, glycine or AMPA, respectively, were not affected. Pretreatment with the α7-nAChR antagonist methyllycaconitine (MLA, 10 nmol/L) blocked the choline-induced negative modulation of the GABA A receptor and the positive modulation of the NMDA receptor. The regulation of the GABA A and NMDA receptors was confirmed using another type of α7-nAChR desensitization, which was produced by a low concentration of choline perfusion. The negative modulation of the GABA A receptor was characterized by choline-duration dependency and intracellular calcium dependency, but the positive modulation of the NMDA receptor was not associated with cytoplasmic calcium. Conclusion: Brain GABA A and NMDA receptors are modulated negatively and positively, respectively, by desensitized α7-nAChR as a result of choline pretreatment in cultured hippocampal neurons.
Introduction
Cholinergic neurons are sparse in the brain, and their projection systems provide broad, diffuse innervation to wide areas of brain [1] . Nicotinic acetylcholine receptors (nAChRs) have been shown to play important roles in rhythmogenesis and cognitive processes and are implicated in a number of neurological and psychiatric disorders [2] . Homopentameric α7-containing nAChR (α7-nAChR), which is easily and rapidly desensitized and has high calcium permeability, is expressed abundantly in the brain [3] and contributes to the pathogenesis of epilepsy, Alzheimer's disease (AD) and schizophrenia [4] [5] [6] .
Notably, these brain diseases are also relevant to the major neurotransmitters, GABA and glutamate. Excessive neuronal excitability resulting from the dysfunction of inhibitory signaling mediated by GABA receptors or the redundant performance of NMDA receptors is believed to be the potential mechanism that underlies epileptogenesis [7] . For AD, the chronic exposure of extrasynaptic NMDA receptors to agonists induces amyloid-β release and promotes neurodegenerative diseases process. A benzodiazepine receptor partial inverse agonist can be applied in the treatment of AD [8, 9] . Thus, it is necessary to explore the relationship between amino acid receptors and α7-nAChRs in the brain.
Brain nAChRs possess resting, activated and desensitized states. Desensitized nAChRs are involved in several biological functions, such as neuroprotection, modulation of synaptic plasticity, and regulation of the release of neurotransmitters [10] .
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Therefore, we designed this study to verify whether desensitized α7-nAChRs can affect the functions of amino acid receptors to further understand the role of cholinergic modulation in the brain.
Materials and methods

Animals
Neonatal Sprague-Dawley rats (postnatal day 0-1, SPF grade) were purchased from the Experimental Animal Center of the Academy of Military Medical Sciences (AMMS, Beijing, China). All animals were handled in accordance with the animal care and use guidelines established by the AMMS, which entail minimizing both the number and the suffering of the animals used for the experiments.
]-cyclohepten-5,10-imine maleate (MK-801), tetrodotoxin (TTX), and 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid (BATPA) were purchased from Sigma (St Louis, MO, USA). Dulbecco's modified Eagle's medium/Ham's F-12 medium (DMEM/F12), Neurobasal-A medium, B-27 supplement, and fetal bovine serum were purchased from GIBCO (Gaithersberg, MD, USA).
The drugs were dissolved in distilled deionized water (DNQX and MK-801 were dissolved in dimethyl sulfoxide) to prepare a stock solution.
Hippocampal neuron preparation
The brains of the rats were removed and placed in icecold phosphate buffer solution (PBS), where they remained throughout the dissection. The PBS contained the following components (in mmol/L): 137 NaCl, 2.7 KCl, 11.6 NaH 2 PO 4 , and 1.47 KH 2 PO 4 . The solution was adjusted to pH 7.4 using NaOH. The hippocampi were isolated rapidly and cut into small pieces and then incubated for 20 min at 37 ºC in PBS containing 2 mg/mL papain. The papain solution was replaced with 5 mL of DMEM/F12 that was supplemented with 10% fetal bovine serum after incubation. Following washing, the digested tissue was gently triturated by suction using a glass pipette. The cells were resuspended in DMEM/F12 that was supplemented with 10% fetal bovine serum, 100 μg/mL streptomycin and 100 IU/mL penicillin in 35-mm-diameter Petri dishes (2 mL/dish) coated with poly-D-lysine and were then maintained in a 5% CO 2 incubator at 37 ºC. One day later, the medium was replaced with a Neurobasal-A medium that was deprived of serum to limit fibroblast proliferation. This medium contained 2% B-27 supplement and 292 μg/mL glutamine to facilitate the survival of hippocampal neurons in vitro. Thereafter, half of the medium was changed every 3 days. The experiments were performed on neurons that had been cultured for 10-15 days.
Patch-clamp whole-cell current recordings Whole-cell currents were recorded from the soma of cultured hippocampal neurons. A MultiClamp 700B amplifier and pClamp 9.2 software (Molecular Devices, Sunnyvale, CA, USA) were used for data acquisition and analysis. Patch pipettes (borosilicate glass with a resistance of 2-4 MΩ) were pulled using a pipette puller (Narishige PP-830, Tokyo, Japan). Membrane currents were sampled at a frequency of 5 kHz and low-pass filtered at 2 kHz. The current capacitances of the pipette and the whole cell were minimized. Before series resistance compensation, a whole-cell access resistance of less than 20 MΩ was accepted. The standard extracellular bathing solution (ECS) contained the following components (in mmol/L): 140 NaCl, 4 KCl, 1 MgCl 2 , 2 CaCl 2 , 10 D-glucose, and 10 HEPES. The solution was adjusted to pH 7.4 with NaOH. TTX (0.5 μmol/L) and atropine (0.5 μmol/L) were added to the extracellular solution to block action-potential firing and muscarinic receptors. When NMDA-induced currents were recorded, Mg 2+ -free ECS plus 3 μmol/L glycine was utilized. Neurons were continuously perfused with extracellular solution (2 mL/min) throughout the duration of the experiments. A gap-free model was used to record the currents after their decomposition into the whole-cell configuration. The pipette solution contained the following components (in mmol/L): 120 CsCH 3 SO 3 , 30 CsCl, 2 MgCl 2 , 4 MgATP, 2 EGTA, 10 HEPES, which was adjusted to pH 7.2 with CsOH. The agonists were focally applied onto the soma of neurons with a puff pipette that was connected to Picospritzer III (Parker Hannifin, Hollis, NH, USA). The puff pipette consisted of three microtubes, two of which were filled with different drugs that were dissolved in the ECS. Pressure was applied to every cell, which did not produce an electrical response. Bath-applied drugs were diluted at final concentrations in the ECS and were delivered to the cell through a perfusion system. All experiments were performed at room temperature (22-25 ºC) .
Data analysis
Statistical analyses were conducted using SPSS 13.0 (SPSS, Chicago, IL, USA). Averaged data are presented as the mean±the standard error of the mean (SEM), and statistical significance was tested using Student's t-test or an ANOVA, when appropriate. P values of <0.05 were considered to be statistically significant. The decay phases of the current tracings were analyzed with the following mono-exponential equation using the Clampfit 9. 
Results
Desensitization properties of α7-nAChRs A rapid pulse of choline (10 mmol/L for 1 s) delivered onto the soma of hippocampal neurons clamped at −80 mV could elicit an inward current that rapidly returned to baseline levels before the end of the choline application. Choline-evoked currents could reversibly or irreversibly be blocked by two specific α7-nAChR antagonists, MLA (10 nmol/L) or α-Bgt (100 nmol/L), respectively ( Figure 1A and 1B).
Here, two methods were used to produce α7-nAChR desensitization. First, we applied a fast pulse of a high concentration of choline (10 mmol/L) to produce classical desensitization. After current stimulation, which is referred to as receptor activation, the rapid decay was represented as receptor desensitization. The decay rate constant (τ) was determined to be approximately 91 ms. To measure recovery from desensitization, two 1-s pulses of choline were applied at different intervals. The intervals between each paired-pulse were longer than 120 s. As shown in Figure 1C , the second current was not observed (representing complete desensitization) when the interval was less than 10 s and partially recovered to the level of the first current (representing partial desensitization) when the intervals were between 20 s and 50 s. When the interpulse intervals were 20, 30, 40, and 50 s, the amplitudes of the second response were 14%±6%, 44%±11%, 69%±5%, and 88%±4%, respectively, of the first response. The second choline-evoked current exhibited a completely recovered response when the interval was 60 s (102%±3% of the first response). A plot of the normalized peak amplitude against the intervals between the paired-pulse was used to calculate the 50% recovery time (t 1/2 ). The data fit well using a logistic regression (r 2 =0.97), and the values of t 1/2 were calculated to be 34.4±4.2 s ( Figure 1D ).
Then, a low concentration of choline (0.1 mmol/L) was continuously perfused (10 min) to induce desensitization without apparent receptor activation, while the response of the receptor was evaluated with a 0.1-s pulse of 10 mmol/L choline. In this experiment, the perfusion of 0.1 mmol/L choline had little effect on the baseline current. When choline was perfused for 1, 3, 6, and 10 min, the amplitudes of the test currents decreased to 58%±13%, 32%±15%, 15%±3%, and 10%±2%, respectively, of the control. The rundown of the cholineinduced response was gradually recovered after the removal of bath-applied agonists ( Figure 1E ). By varying the concentrations of choline from 0.01 to 10 mmol/L, the sustained perfusion of choline was used to study the concentration dependence of desensitization. After 10 min of bath application of choline, the response to the test pulse began to decrease from 0.025 mmol/L and disappeared completely at concentrations greater than 0.5 mmol/L ( Figure 1G ). The analysis of the concentration dependence with logistic regression (r 2 =0.99) yielded an IC 50 for a desensitization of 46.6 μmol/L (95% confidence interval is 44.8 to 48.4 μmol/L; Figure 1H ).
Desensitized α7-nAChR modulates amino acid receptors
The modulatory effects of the desensitized α7-nAChR on GABA A , glycine, AMPA, and NMDA receptors were investigated in this experiment. A puffer pulse of muscimol (10 µmol/L for 1 s), glycine (100 µmol/L for 1 s), AMPA (10 µmol/L for 5 s), and NMDA (100 µmol/L for 5 s) elicited four types of fast-activating, inward currents in these four receptors, respectively, and all could be reproducibly elicited at 120 s intervals. The blockade of these receptors by bicuculline (10 µmol/L), strychnine (1 µmol/L), DNQX (10 µmol/L), and MK-801 (10 µmol/L) confirmed that these currents were mediated by GABA A , glycine, AMPA, and NMDA receptors, respectively (Figure 2A and 2B) .
We first studied the effects of classical desensitization that was induced by a high concentration of choline. In this experiment, a brief pulse of choline (10 mmol/L for 1 s) prior to the application of muscimol caused a significant reduction in the peak amplitudes of the muscimol-evoked currents when the intervals between the termination of the choline pulse and the initiation of muscimol administration were 2 s and 10 s. The reduction was cancelled when the interval was longer than 30 s ( Figure 2C ). The choline-evoked currents immediately returned to a baseline level before the application of muscimol. Thus, the inhibition was independent of whether there were any changes to the baseline current induced by choline. The opposite result was obtained in the experiment that was performed on the NMDA receptor. The amplitude of the NMDA response was increased after a choline pulse when the interval between choline and NMDA was 2 s, and the enhancement disappeared when the interval was longer than 10 s ( Figure  2D ). Finally, we failed to record any detectable changes in the amplitudes of glycine or AMPA-evoked currents using the same methods ( Figure 2E and 2F) .
Then, MLA was applied to study whether these effects were mediated by the α7-nAChR. We confirmed that the interval between choline and muscimol or NMDA was 2 s. We then compared the effects of the choline pulse on the two receptors before and after MLA perfusion. Bath-applied MLA (10 nmol/L) abolished the reduction in the amplitudes of the muscimol-evoked currents (82%±2% of the control level in the normal solution vs 102%±5% of the control level in the MLAcontaining solution) ( Figure 3A and 3B) and the enhancement in the amplitudes of the NMDA-evoked currents (113%±3% of the control level in the normal solution vs 101%±1% of the control level in the MLA-containing solution) ( Figure 3C and 3D). The evidence provided by the use of the antagonist MLA indicates a possible role for α7-nAChR in these effects.
Finally, we perfused low concentrations of choline to test the effect of the α7-nAChR on the GABA A or NMDA receptor. When 0.1 mmol/L choline was perfused for 1, 3, 6, and 10 min, the amplitudes of the muscimol-induced currents decreased to 96%±2%, 92%±2%, 89%±3%, and 84%±3%, respectively, of the control. Furthermore, the reduction of the muscimol-evoked current was partially recovered after the removal of bath-applied choline ( Figure 4A and 4B) . For the NMDA receptor, 0.1 mmol/L choline perfusion could not induce significant changes in the NMDA-evoked current. Conversely, when the concentration of choline perfusion was greater than 0.5 mmol/L, we observed the reversible Figure 4C and 4D). Because low concentration choline perfusion induced desensitization without receptor activation, these data demonstrate that the effects on GABA A and NMDA receptors are associated with desensitized α7-nAChR.
Mechanisms underlying the modulation of the GABA A or NMDA receptor by the desensitized α7-nAChR As the duration of agonist exposure influenced the recovery of the nAChRs from desensitization, we studied the effect of duration of the choline pulse on the above-mentioned modulatory actions. By varying the duration of the choline pulse at a similar interval of 2 s, we observed that both the inhibition of the GABA A receptor and the potentiation of the NMDA receptor increased in the presence of a prolonged duration of exposure to choline. At pulse durations of 0.1, 1, and 10 s in the same cell, the amplitudes of the muscimol-evoked current were 89%±2%, 85%±3% and 75%±2% of the control level, respectively ( Figure 5A ), and the amplitudes of the NMDAevoked current were 99%±2%, 107%±2% and 112%±3%, respectively, of the control level ( Figure 5C ). α7-nAChR is characterized as having a high Ca 2+ permeability. Thus, cytoplasmic Ca 2+ influx via the α7-nAChR may be involved in the modulatory action of choline on the GABA A or NMDA receptor. The Ca 2+ chelator BAPTA (10 mmol/L) was injected into a pipette solution to test the role of intercellular Ca 2+ . Here, choline elicited an inward current in a BAPTA-containing pipette solution, which was similar to what was observed using the normal intracellular solution. The introduction of BAPTA into neurons through a pipette Figure 6C ). These data demonstrate that cytoplasmic Ca 2+ has a role in the choline's inhibition of the GABA A receptor but does not participate in potentiation of the NMDA receptor.
Discussion
The present study demonstrates that the desensitization of α7-nAChR by choline selectively modulates the functions of amino acid receptors (ie, α7-nAChR desensitization reversibly depresses the GABA A receptor and enhances the NMDA receptor but does not affect glycine or AMPA receptor). Moreover, the depression of GABA A is associated with the duration of choline administration and the level of intracellular Ca 2+ . The NMDA response is also enhanced, which depends on the duration of choline but is independent of cytoplasmic Ca
2+
. As GABA A and NMDA receptors in the hippocampus are important for network oscillations and cognitive processes, these actions may enlarge the effect of α7-nAChR desensitization on the regulation of the excitatory rhythm of local neuronal circuits and the modulation of synaptic plasticity.
Many studies have proven the idea that cholinergic neurotransmission in the brain is primarily neuromodulatory [1] . As one part of the cholinergic system, nAChRs act through their natural agonists: ACh and choline. Choline is a selective agonist of the α7-nAChR. In our study, the induction of a fast activating/desensitizing current, which is sensitive to MLA and α-Bgt, by choline confirmed that choline-evoked currents were generated through the α7-nAChR. The modulatory effects of choline depend mainly on its concentration. The high frequency of ACh release and its enzymolysis by nearby acetylcholine esterase would likely produce choline at relatively high concentrations. In this condition, α7-nAChR is first activated and then desensitized with a subsequent recovery after agonist removal. This process is regarded as "classical desensitization" [11] . Here, a paired pulse was used to study recovery from the desensitization of the α7-nAChR that was induced by a high concentration of choline. After the first pulse, the second choline-induced response was not observed when the interval was less than 10 s, which was partially recovered when the interval was between 20 s and 50 s and was completely recovered when the interval was 60 s. The three periods represent complete desensitization, partial desensitization and full recovery of the α7-nAChR. Conversely, free extracellular choline in the cerebrospinal fluid is approximately 5-10 µmol/L, whereas this level can be 
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Acta Pharmacologica Sinica npg elevated (3-4 fold) under several conditions, such as ischemia, stroke, hypoxia, and substantial plasma membrane damage [12] . The basal level of choline is far lower than the efficacious concentration that is necessary to activate α7-nAChRs; however, it is sufficient to desensitize α7-nAChRs. This type of desensitization is a slow process, has a high affinity for agonists and can be produced by long term perfusion of low concentrations of choline [11] . Thus, choline has a central physiological action that mainly depends on desensitizing α7-nAChRs.
Brain nAChR desensitization protects cells against excessive stimulation and participates in several types of neural activities [13] . As a particular functional state, and according to our previous reports, the desensitization of nAChRs not only results in its loss of gating ability to open channels but also adjusts the activities of other receptors, (ie, it facilitates the function of muscarinic receptors [14] or dopamine receptors [15] ). This experiment suggests that desensitized α7-nAChRs depresses the response of the GABA A receptor to its agonist and facilitates the response of the NMDA receptor. The main finding was obtained via three experiments. We first examined the change in the muscimol or NMDA-induced response during recovery from desensitization after a 10 mmol/L choline pulse and then employed MLA to determine a possible role for α7-nAChR and finally perfused a low concentration of choline to study the role of receptor desensitization. Our conclusion concerning the depression of GABA A receptor activity in our report is similar to that of a previous study involving hippocampal slices and knockout mice [16] . They observed that the activation of cholinergic fibers by electrical stimulation could reduce the subsequent GABA A receptor-mediated currents. Furthermore, this reduction was absent in hippocampal slices that were obtained from α7-nAChR knockout mice. In contrast to their results, we presumed that the desensitization of the α7-nAChR was the cause of the downregulation of the GABA A receptor because 0.1 mmol/L choline perfusion did not evoke apparent receptor activation but was sufficient to induce a desensitized receptor. In addition, the GABA A receptor appeared to be more sensitive to α7-nAChR desensitization than the NMDA receptor. This was concluded because the depression of the muscimol response occurred within 10 s after a choline pulse and 10 min after 0.1 mmol/L choline perfusion, whereas potentiation of the NMDA response appeared within 2 s after agonist removal and 10 min after 0.5 mmol/L choline perfusion. Furthermore, a 0.1-s choline pulse significantly inhibited the muscimol-evoked current but did not affect the NMDA-induced current. According to previous studies, prolonging the duration of agonist exposure or increasing the agonist concentration can induce nAChRs to enter into greater depths of desensitized states [17] . Thus, a deeper desensitized state of the α7-nAChR is more important for regulating the function of the NMDA receptor than for regulating the function of the GABA A receptor. npg Intracellular Ca 2+ was a possible effector that was evolved in the depression of the GABA A receptor after the choline pulse because the Ca 2+ chelator BAPTA abolished this action of choline, which is similar to the results that were obtained for induction by nicotine and ACh [16] . The influx of Ca 2+ through nAChRs has been shown to directly or indirectly participate in regulating the desensitization of nAChRs [18] through protein kinase activation, such as an increase in intracellular Ca 2+ , which enhanced the onset of nAChR desensitization, or a decrease in intracellular Ca 2+ by chelation with BAPTA. This accelerates the recovery from desensitization of nAChRs and, according to our studies, also modulates the following inhibition of GABA A receptors by choline. Now, this effect could be regarded as one event of receptor-crosstalk through Ca 2+ -dependent signal transduction. Nevertheless, intracellular Ca 2+ had no effect on potentiation of the NMDA receptor. The Ca 2+ -independent mechanism may result from the action of other minor ions through α7-nAChRs, such as Na + , or membrane lipid composition, such as the metabolites of arachidonic acid. These effectors also regulate the desensitizing processes through its allosteric effects [19] . Moreover, further studies will be required to understand the details of how the desensitization of α7-nAChR influences the function of GABA A and NMDA receptors.
The modulation of GABA A or NMDA receptors by α7-nAChR desensitization may be a new pathway of cholinergic innervation. The hippocampus, which is the center of cognitive and memory function, is sensitive to cholinergic modulation by the medial septum/diagonal band of Broca. Furthermore, the desensitization of α7-nAChR in the hippocampus is important for the regulation of neuronal excitability and synaptic communication because cholinergic receptors are frequently expressed in glutamatergic and GABAergic terminals [20] . Several reports have recently focused on the interactions between α7-nAChR and GABA A receptors. For example, α7-nAChR facilitates the TTX-sensitive release of GABA, which regulates the activities of pyramidal neurons [21] . Specific agonists of the α7-nAChR elicit an inward current in interneurons [22] . At synaptic sites, the desensitization of presynaptic α7-nAChR decreases the release of GABA from GABAergic neurons or increases glutamate release from glutamatergic neurons after repetitive exposure to nicotine [23, 24] . According to our report, cholinergic axons may regulate the excitatory rhythm of local neuronal circuits by desensitizing α7-nAChR. When exposed to fluctuant and low concentrations of choline, α7-nAChR transforms from a resting state to a desensitized state, from which it is able to subsequently recover. This transformation will regulate the activities of nearby GABA A or NMDA receptors, thereby altering local excitability. Neuronal nAChRs, especially the α7 subtype, have previously been related to multiple forms of time-dependent plasticity [25] . Acute or chronic nicotine treatment can facilitate long-term potentiation (LTP) by decreasing the threshold for LTP induction in the hippocampal CA1 region [26] . In hippocampal slices, exposure to nicotine promotes the induction of NMDA-mediated LTP [27] . According to our results, these events of synaptic plasticity in the hippocampus may be regulated by the effect of the desensitization of α7-nAChR on amino acid receptors, because the activation of the NMDA receptor directly induces LTP, whereas activation of the GABA receptor results in modulation of synaptic plasticity through a change in cellular excitability [28, 29] . In conclusion, our study provides insight into a mechanism by which the desensitization of α7-nAChR modulates cellular excitability and synaptic activity. The effect of this desensitization depends mostly upon the negative modulation of the GABA A receptor, as well as the positive modulation of the NMDA receptor.
